Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases

Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction

(2011) Patrick Rossignol et al.   CIRCULATION

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function

(2011) Frank A. Holtkamp et al.   KIDNEY INTERNATIONAL

Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease

(2011) Jean-Philippe Bertocchio et al.   KIDNEY INTERNATIONAL

Aldosterone: effects on the kidney and cardiovascular system

(2010) Marie Briet et al.   Nature Reviews Nephrology

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

(2010) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker

(2008) Yoshiyuki FURUMATSU et al.   HYPERTENSION RESEARCH

Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan

(2008) L. Vogt et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?

(2008) Michael Gekle et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY